Matteo Candeloro

MD, PhD, Geriatrician. Research fellow at @univUda. In love with #Abruzzo! Views are my own.

[Nicola Potere @NicolaPotereMD]

📌#ASH24. 🔜🔔Looking forward to discussing #thromboinflammation of #cancer associated #thrombosis‼️
Join us today from 2:00pm PT

@jzbos @Lbkreuziger @nayaklalitha1 @AngLi_MD @science_brake @jd_beckman & other outstanding presenters

[Nicola Potere @NicolaPotereMD]

Kicking off #WorldThrombosisDay in Pescara, 🇮🇹! Come visit us! #StopTheClot #WTDay24

@MarcelloDiNisio @Matteocandeloro @univUda @thrombosisday

[Ash Paul @pash22]

Scientists need more time to think
https://t.co/pmA1A2bINt via @Nature

[Marc Carrier @MarcCarrier1]

Dr. @NicolaPotereMD reported that older age, low BMI, thrombocytopenia and renal impairment are associated with decision to use low dose DOAC for secondary prevention in patient with VTE. No difference in recurrent VTE or major bleeding between the two groups at #ISTH2024

[Marc Carrier @MarcCarrier1]

Dr. @NicolaPotereMD reported that 15.5% of patients with distal DVT had recurrence following anticoagulation discontinuation. Patients with unprovoked events or diabetes and those only receiving 6 weeks of anticoagulation, are at higher risk of recurrent events! #ISTH2024

[Società Italiana di Gerontologia e Geriatria @GeriSocITA]

📆 Save the Date 
Congresso Regionale #SIGG Sezione Abruzzo-Molise
Comune di Ortona, Sala Eden - 24-25 maggio 2024

Per info e programma: https://t.co/kV086AiOI6

[Società Italiana di Gerontologia e Geriatria @GeriSocITA]

Il #gruppoYES e la sezione giovani di @itacare_p vi invitano al primo webinar intersocietario “La prescrizione dell’esercizio fisico nell’anziano”

🔗 https://t.co/kiFCcsDU64

[Stefano Cacciatore @stecacMD]

Glad to share the results of our nationwide survey on #research, clinical and theoretical training among #geriatric medicine residents in Italy #LucaSoraci @EnricoBr1MD #DavideMontini @Chuma_OkoyeMD @Cate_Trevisan #PanaiotisFinamore #IlariaParrotta @leonardobenciv @Matteocandeloro @Diana43486012 and the #gruppoYES @GeriSocITA https://t.co/YH3Tcfx1TU

[Jerrold Levy, MD @JerroldLevy]

Management of patients on antithrombotic therapy with severe infections: clinical consensus statement of the @ESC, @ISTH led by Drs BGigante , BRocca, SSchulman now online @ESC_Journals https://t.co/asfA6vAp0z

[WHO Collaborating Center for Frailty @WHOCenterFrailt]

Effectiveness of different exercise types for older adults with sarcopenia in "Exercise for sarcopenia in older people: A systematic review and network meta-analysis" https://t.co/zDZyHuZMkF @brunovellas @mikelizquierdo_ @JuanluSanchez5

[Nicola Potere @NicolaPotereMD]

Hot off the press @JACCJournals

🔥Inflammasome Signaling, Thromboinflammation, and Venous Thromboembolism🫁🦵

https://t.co/68Q0wfam7N #CardioTwitter #ACC #cvCoag #inflammation #thrombosis

[Nicola Marino @nikmarino9]

Ricordate l’antidiabetico semaglutide, utilizzato off-label per dimagrire?

Tra gli adulti con sovrappeso/obesità, dopo una sostanziale riduzione del peso corporeo durante 68 settimane di trattamento con una somministrazione settimanale associata ad un cambiamento dello stile di vita, la successiva sospensione del trattamento ha portato al recupero della maggior parte della perdita di peso entro 1 anno e un cambiamento simile in alcune variabili cardiometaboliche al basale.

La perdita di peso e il miglioramento del profilo cardiometabolico nel lungo periodo si raggiunge con una personalizzazione dello stile di vita alimentare, attività fisica, sonno e stress.

Il messaggio è di evitare di prendere farmaci inutili e, peraltro, esporsi al rischio di controindicazioni.

#Longevità @AurelianoStingi

[RPTH @RPTHjournal]

Is concomitant administration of DOACs and anti-epileptic drugs safe in clinical practice? 💊

Latest updates from literature:
https://t.co/0vWvgS5vYu

@matteocandeloro

[Nicola Potere @NicolaPotereMD]

Apixaban #thromboprophylaxis in ambulatory patients with #cancer and #obesity: Insights from the #AVERT trial

@MarcCarrier1 @PhilWellsMD1 @TzufeiWang @DellucAurelien @VTagalakis @MarcelloDiNisio @sudeeppappur

#MedTwitter #cvCoag #vte
https://t.co/W227YPYw6C| @ThrombosisRese1

[Chukwuma Okoye @Chuma_OkoyeMD]

Insighful Editorial by McDonagh et al in #Heart,Lung, Circulation
"When will
#frailty move from being merely a predictor of mortality in
clinical studies to a clinically meaningful index capable
of guiding #HeartFailure management?"
It is time to move a step forward.
#geriatrics

[manuel monreal @mmonrealriete]

Find it here: https://t.co/t5uh8HvbX9

[Dr Jean Pierre Laroche @Echoraljpangio]

RIETE EXPRESS : TV splanchniques asymptomatiques https://t.co/YfzWUnrt6S via @Echoraljpangio @grelegal @grepmeded @MarcCarrier1 @RodgerMarc @rosencher @CorinneFrereMD @GodierAnne @GFHT_Hemostase @GIHP_official @ahmedhatri2 @BNacerra @VirginieDufrost @CarolineFGD1 @lasfmv

[Davide L Vetrano @DLVetrano]

Screening #frailty in #primarycare using the Primary Care Frailty Index (PC‑FI), built using GPs health records from >300k Italian patients and validated externally.

https://t.co/2qCso5nrNj

@Albe_Zucc @GrazianoOnder @ale_marengoni @AmaiaCalderon @InfoSIMG

[CAS-AM @CAS_AM_eu]

Exciting day in training the new antithrombotic management experts: Portfolio Discussions with faculty. More at https://t.co/33ZmBLcVRN